Advertisement

La surveillance après orchidectomie : pour qui ? Comment ?

  • A. Houlgatte
Chapter
  • 189 Downloads
Part of the Monographies en urologie book series (MONOGRAPHIES)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Peckam MJ, Barrett A, Husband JE et al. (1982) Orchidectomy alone in testicular stage I non-seminomatous germ cell tumours. Lancet 2: 678–80Google Scholar
  2. 2.
    Colls BM, Harvey VJ, Skelton L et al. (1999) Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumours: 17 years’ experience in a national study in New Zealand. Br J Urol 83: 76–82Google Scholar
  3. 3.
    Nicolaï N, Pizzocaro G (1995) A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10 year followup. J Urol 154: 1045–9PubMedGoogle Scholar
  4. 4.
    Sharir S, Jewett MAS, Sturgeon JFG et al. (1999) Progression detection of stage 1 nonseminomatous testis cancer on surveillance: implications for the followup protocol. J Urol 161: 472–6PubMedGoogle Scholar
  5. 5.
    Alexandre J, Fizazi K, Mahe C et al. (2001) Stage 1 non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low relapse. Eur J Cancer 37: 576–82PubMedCrossRefGoogle Scholar
  6. 6.
    Spermon JR, Roeleveld TA, van der Poel HG et al. (2002) Comparison of surveillance and retroperitoneal lymph node dissection in stage I nonseminomatous germ cell tumors. Urology 59: 923–9PubMedCrossRefGoogle Scholar
  7. 7.
    Napier MP, Rustin GJS (2000) Diagnostic delay and risk of relapse in patients with stage I nonseminomatous germ cell tumour followed on active surveillance. Br J Urol 86: 486–9Google Scholar
  8. 8.
    Leibovitch I, Foster RS, Kopecky KK et al. (1998) Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitative immunohistochemical, histopathologic, and radiologic assesment. J Clin Oncol 16: 261–8PubMedGoogle Scholar
  9. 9.
    Fossa SD, JAcobsen AB, Aass N et al. (1994) How safe is surveillance in patients with histologically low-risk nonseminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources ? Br J Cancer 70: 1156–60PubMedGoogle Scholar
  10. 10.
    Gels ME, Hoekstra HJ, Sleijfer DT et al. (1995) Detection of recurence in patients with clinical stage 1 nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10 year experience. J Clin Oncol 13: 1170–2Google Scholar
  11. 11.
    Klepp O, Dahl O, Flodgren P et al. (1997) Risk-adapted treatment of clinical stage 1 nonseminomatous testis cancer. Eur J of Cancer 33: 1038–44Google Scholar
  12. 12.
    Baniel J, Foster RS, Gonin R et al. (1995) Late relapse of testicular cancer. J Clin Oncol 13: 1170–5PubMedGoogle Scholar
  13. 13.
    Hao D, Seidel J, Brant R et al. (1998) Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance. J Urol 160: 768–71PubMedGoogle Scholar
  14. 14.
    Sweeney CJ, Hermans BP, Heilman DK et al. (2000) Results and outcome of retroperitoneal lymph node dissection for clinical stage 1 embryonal carcinoma-predominant testis cancer. J Clin Oncol 18: 358PubMedGoogle Scholar
  15. 15.
    Amato RF, Ro JY, Ayala AG, Swanson DA (2004) Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis. Urology. 63: 144–9PubMedCrossRefGoogle Scholar
  16. 16.
    Francis R, Bower M, Brunström G et al. (2000) Surveillance for testicular germ cell tumours: results and cost benefit analysis of management options. Eur J Cancer 36: 1925–32PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag France, Paris 2006

Authors and Affiliations

  • A. Houlgatte
    • 1
  1. 1.Service d’urologie du Pr HoulgatteHôpital d’Instruction des Armées du Val-de-GrâceParis Cedex 05

Personalised recommendations